Dr Reddys Laboratories (RDY) Return on Assets [ROA] (2009 - 2026)
Dr Reddys Laboratories (RDY) reported Return on Assets [ROA] of 71.49% for the quarter ended Jun 30, 2026, up 62.93 percentage points from 8.56% a year earlier but down 0.50 percentage points from the prior quarter.
Powered by 
Analysis
Dr Reddys Laboratories (RDY) Return on Assets [ROA] (2009 - 2026) Analysis & Trends
For the year ended Mar 31, 2026, Dr Reddys Laboratories posted Return on Assets [ROA] of 7.57%, down 5.43 percentage points from the prior year.
- Return on Assets [ROA] has a five-year change of +0.53 percentage points (years ended Mar 2021 to Mar 2026).
- By year, Return on Assets [ROA] came in at 13.00% in the year ended Mar 31, 2025 (-2.60 pp), 15.60% in the year ended Mar 31, 2024 (+1.50 pp), 14.09% in the year ended Mar 31, 2023 (+5.79 pp) and 8.30% in the year ended Mar 31, 2022 (+1.27 pp).
- Five-year quarterly Return on Assets [ROA] spans a low of 6.30% in the quarter ended Sep 30, 2024 and a high of 71.99% in the quarter ended Mar 31, 2026.
- Year over year, Return on Assets [ROA] has now increased in each of the last six quarters, with an average year-over-year change of +17.78 percentage points over the last eight quarters.
- The high point for year-over-year Return on Assets [ROA] in five years was the quarter ended Mar 31, 2026 (a gain of 63.10 percentage points); the low point was the quarter ended Sep 30, 2024 (a drop of 9.24 percentage points).
- Per Business Quant data, the three quarters before the quarter ended Jun 30, 2026 came in at 71.99% (quarter ended Mar 31, 2026), 33.68% (quarter ended Dec 31, 2025) and 8.26% (quarter ended Sep 30, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROA (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 10.47% |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 4.65% |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 2.45% |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 28.37% |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 9.10% |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 9.29% |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | -6.13% |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 2.14% |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 16.34% |
| 10 | Dr Reddys Laboratories | 10.53 Bn | 9.72 Bn | 396.53 Mn | 71.49% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 71.49% |
| Mar 31, 2026 | 71.99% |
| Dec 31, 2025 | 33.68% |
| Sep 30, 2025 | 8.26% |
| Jun 30, 2025 | 8.56% |
| Mar 31, 2025 | 8.88% |
| Dec 31, 2024 | 8.64% |
| Sep 30, 2024 | 6.30% |
| Jun 30, 2024 | 7.28% |
| Mar 31, 2024 | 7.92% |
| Dec 31, 2023 | 12.40% |
| Sep 30, 2023 | 15.54% |
| Jun 30, 2023 | 15.41% |
| Mar 31, 2023 | 15.41% |
| Dec 31, 2022 | 11.72% |
| Sep 30, 2022 | 9.77% |
| Jun 30, 2022 | 7.93% |
| Mar 31, 2022 | 7.48% |
| Dec 31, 2021 | 9.35% |
| Sep 30, 2021 | 10.83% |
API Access
Dr Reddys Laboratories Return on Assets [ROA] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=RDY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-assets-[roa]", "ticker": "RDY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-assets-%5Broa%5D&ticker=RDY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();